Galena Biopharma, Inc. (GALE) - Up and Coming Stocks 2012

Galena Biopharma, Inc. (GALE) is having a huge rally in 2012 and is one of the up and coming penny stocks in 2012. GALE has news out which is causing the stock to test It's 200 day moving average in pre market.
 

Galena Biopharma Initiates Patient Enrollment in NeuVax(TM) Phase 3 PRESENT Trial to Prevent Breast Cancer Recurrence
 

NeuVax adjuvant therapy intended for patients not eligible for Herceptin® (trastuzumab) therapy

Phase 3 trial being conducted under FDA-approved Special Protocol Assessment; initiated ahead of schedule

LAKE OSWEGO, Jan. 20, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced the initiation of its Phase 3 PRESENT trial for NeuVax™ (E75 peptide plus GM-CSF) vaccine in HER2 1+ and 2+ breast cancer patients (often referred to as HER2 negative) in the adjuvant setting to prevent recurrence.
 

"Approximately fifty percent of breast cancer patients have tumors that are HER2 1+ or 2+. These patients are successfully rendered disease-free following treatment with current standards of care, and then are sent home to watch and wait with the hope their cancer never returns. Our encouraging findings from the previous Phase 1/2 clinical trial show that NeuVax may provide a significant benefit to maintain disease-free survival in these patients who have no other [adjuvant therapy/treatment] options," added Beth Mittendorf, M.D., Assistant Professor, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center and principal investigator for the PRESENT Phase 3 study.
 

http://investors.galenabiopharma.com/releasedetail.cfm?ReleaseID=64...